Top Markets
#1 PulseChain PulseChain +45.01%
#2 Bitway Bitway +13.54%
#3 Meteora Meteora +10.37%
#4 Glidr Glidr +9.69%
#5 SkyAI SkyAI +8.31%
#6 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +7.80%
#7 Unit Pump Unit Pump +7.72%
#8 Pump.fun Pump.fun +7.72%
#9 OPENLOOT OPENLOOT +7.42%
#10 Starpower Starpower +6.76%
Coin of the day
PulseChain PulseChain
Settings
Language
ENGLISH
Currency
USD
Theme
Raphael Pharmaceutical Inc. Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc.

RAPH
Rank in Stocks #28150
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating... Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
Share Price
$1.40
Last synced: 2026-08-18
Market Cap
$28.25M
Change (1 day)
0.00%
Change (1 year)
536.36%
Country
IL
Trade Raphael Pharmaceutical Inc. (RAPH)

Category

Healthcare
Revenue for Raphael Pharmaceutical Inc. (RAPH)
Revenue in Aug 2026 TTM: 0
According to Raphael Pharmaceutical Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Raphael Pharmaceutical Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN